Medication Consultation & Review is categorized under Unclassified in Cape Coral, FL and active since 2007.
Medication Consultation & Review was established in 2007, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Unclassified business, which does work in the B2B market, and is classified as a Unclassified, under code number 561990 by the NAICS.
If you are seeking more information, feel free to contact M Richardson-Crawford at the company’s single location by writing to 1308 Se 5th Terrace, Cape Coral, Florida FL 33990 or by phoning (239) 772-1606. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Medication Consultation & Review |
| Contact Person: | M Richardson-Crawford |
| Address: | 1308 Se 5th Terrace, Cape Coral, Florida 33990 |
| Phone Number: | (239) 772-1606 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Unclassified |
| SIC Code: | 7389 |
| NAICS Code: | 561990 |
| Share This Business: |
Medication Consultation & Review was started in 2007 to provide professional Unclassified under the SIC code 7389 and NAICS code 561990. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact M Richardson-Crawford for inquiries that concern Medication Consultation & Review by calling the company number (239) 772-1606, as your correspondence is most welcome. Additionally, the physical location of the single location of Medication Consultation & Review can be found at the coordinates 26.642523,-81.946716 as well as the street address 1308 Se 5th Terrace in Cape Coral, Florida 33990.
For its online presence, you may visit Medication Consultation & Review’s website at and engage with its social media outlets through on Twitter and on Facebook.